Article
Real-world outcomes of chemotherapy for lung cancer patients undergoing hemodialysis: A multicenter retrospective cohort study (NEJ-042).
Lung cancer (Amsterdam, Netherlands) - 1 Oct 2022
Minegishi Yuji, Akagami Tomoe, Arai Makoto, Saito Ryota, Arai Daisuke, Murase Kyoko, Miura Keita, Watanabe Satoshi, Sakashita Hiroyuki, Miyabayashi Takao, Honda Ryoichi, Jingu Daisuke, Hotta Takamasa, Isobe Kazutoshi, Nakazawa Kensuke, Ito Kenichiro, Takamura Kei, Inomata Minehiko, Harada Toshiyuki, Sakakibara Rie, Nakagawa Taku, Shibuya Hideki, Takenaka Kiyoshi, Kobayashi Kunihiko, Seike Masahiro
Abstract excerpt
INTRODUCTION: Malignant tumors are the major cause of death in hemodialysis patients. Management of these patients remains challenging as there is no evidence that chemotherapy is beneficial, and a lack of information about actual clinical practice. METHODS: This multicenter retrospective study included hemodialysis patients who were diagnosed with lung cancer from January 2002 to June 2018. We reviewed their...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.